Smallpox monoclonal antibody

Details for Australian Patent Application No. 2007342327 (hide)

Owner Quercegen Pharma LLC

Inventors Kinet, Jean-Pierre; Jouvin, MarieHelene

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007342327

PCT Pub. Number WO2008/085551

Priority 60/839,579 23.08.06 US

Filing date 22 August 2007

Wipo publication date 17 July 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

26 March 2009 PCT application entered the National Phase

  PCT publication WO2008/085551 Priority application(s): WO2008/085551

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007342333-Alphavirus replicon particles encoding IL12 as immunological adjuvants

2007342322-Flat-fold respirator with monocomponent filtration/stiffening monolayer